Since 2018, the financing of medical imaging field inventory

According to the incomplete statistics created by Flint, from 2018 to the present, there have been a total of 14 financing incidents in the domestic medical imaging field, of which 6 were publicly disclosed and the total amount exceeded 830 million.

The medical imaging market is medical in recent years health The reason for investing in the field is, on the one hand, that its own market potential is huge. With the rapid growth of patient demand, the revenue from imaging inspection in medical institutions can account for more than 10% of the total hospital revenue. drug After accounting for revenue, on the other hand, the collection of technologies such as medical imaging and artificial intelligence, medical informatization, gave birth to many new application scenarios and business models, which greatly expanded market opportunities.

In the field of traditional medical imaging equipment, high-end equipment has been monopolized by international giants for a long time. Domestic equipment occupies a relatively high market share in the primary market with its price advantage. At the same time, with the adjustment of national policies, classification and treatment, third-party imaging The center has further promoted the growth of demand for grassroots imaging equipment. Leading domestic manufacturers, including Shanghai United Shadows, Mindray Medical, and Neusoft Healthcare, have gradually gained a larger market in high-end and mid-end equipment, as R&D accumulation and technological progress have advanced. Competitiveness, is expected to gradually achieve localization alternatives.

The cross-border integration of imaging technologies has also given rise to new formats, such as artificial intelligence assisted in image diagnosis and reading, video informationization, remote imaging platforms and services. Not only a number of innovative start-up companies have emerged, but also equipment manufacturers. With its own advantages to the downstream extension of the industrial chain.

The data show that by 2020, the overall market size of medical imaging in China will reach 600 billion yuan - 800 billion yuan. According to the incomplete statistics created by Flint, from 2018 to the present, there have been a total of 14 financing events in the domestic medical imaging field, among which the publicly disclosed amount There are 6 of them, and the total amount is more than 830 million. Compared with the past two years, the financing round has already shown the trend of being dominated by the middle and late periods, and still continues the single financing amount larger, concentrated in Beijing, Guangdong, and Shanghai. And the status of these places in Zhejiang. From the financing point of view, medical imaging + AI is still the hottest area of ​​investment.

From 2018 to the present, some financial events in the field of medical imaging

Huiying Huiying was established in April 2015. It uses medical imaging as an entry point to provide image cloud systems, image recognition and intelligent diagnostic services. It is based on cloud computing, big data, and artificial intelligence technologies, providing a 'smart image cloud platform'. Digital smart film, tumor radiotherapy cloud platform, big data intelligent analysis cloud platform, image intelligent screening system and artificial intelligence diagnostic cloud platform's six core services.

The data show that Huiying Huiying in the field of medical imaging AI in 2017 to expand: To more than 700 hospitals, providing intelligent auxiliary diagnosis and quantitative reports, covering the lungs, prostate, breast, fractures, head, etc. up to ten Two different diseases in different parts of the site, and in October 2017, they received a few hundred million yuan in round B funding led by Delta Capital.

The investor in this round of financing was CDH Investment. The A round of investment party Lanchi Ventures continued to follow the investment. It was also the first investment in the AI ​​field in 2018. Huihui Huiying stated that it will gradually develop the 2C business model in the future.

Hangzhou Lianzhong Medical Technology Co., Ltd. is a national high-tech company dedicated to the Internet + medical field enterprise , With a number of qualifications such as provincial-level enterprise research institutes. The company's independent research and development of 'global imaging' cloud medical service platform is a cross-regional, cross-system full medical data sharing, medical + Internet technology platform.

The current round of financing is Lianzhong Healthcare's financing from the funds led by the previous round of Zheshang Ventures Co., Ltd., which will receive nearly 100 million yuan of financing. The funds raised will be used to further tap the contracted image cloud platform project and continue to increase research and development. Strive to further develop new areas.

Sunshine image hospital The Group was established in 2014 by several Chinese medical imaging industry elites. It specializes in the investment and operation of medical imaging centers, the development of medical imaging cloud platform technology, and medical imaging. Talent Cultivating, the corresponding three core businesses include independent medical imaging center, medical imaging cloud service, medical imaging college. Through the establishment of three major business systems, Yimai Sunshine integrates a hierarchical diagnosis and treatment system, and has established more than 50 medical imaging centers covering Beijing. In Jiangxi, Zhejiang, Shandong, Guangxi, Guangdong, Liaoning, Jilin, Hubei, Hunan, Inner Mongolia and other regions, the number of daily inspections exceeded 10,000, creating a cloud platform with a total of 1 million image data, and accumulatively training thousands of people. Medical Imaging Academy of Imaging Doctors.

This round of investment was led by Baidu Capital, A-round investor Goldman Sachs, Xinyi Capital continued to invest in additional funds, Zeyue Capital, Huaxin Century, Huayu Financial and other institutions involved in the follow-up investment. After the completion of Round B financing, a pulse of sunshine will be Under the image-leading clinical and clinical services as the core development strategic goals and supporting system, the company continued to focus on medical operations, talents, and technical elements to deepen integration, creating a 2.0 version of China's leading third-party medical imaging group.

'AI+ Medical Image' The company has proposed Technology was founded in January 2016. It is a technology company that uses artificial intelligence for medical services. Based on medical image data, it analyzes and compares corresponding clinical data, including clinical reports and laboratory research data. To tap the relevance behind the data and provide medical solutions. At present, we think that technology has three mature product lines: X-ray products, lung CT, and stroke.

Since its inception, it has been assumed that the technology has obtained four rounds of financing. As early as February 2016, it was assumed that Tech has won the Innocent Fund, Jinyun Ventures and Yuan Kuai CEO Lv Chuanwei’s personal 12.5 million Angel Wheel Financing; January 2017 Obtained the investment led by Sequoia Capital, the direct investment department of GF Securities followed the investment of 50 million yuan in Series A financing; in September 2017, he was again led by Qiming Venture Capital, Yuansheng Capital, the 120 million yuan B round of Sequoia China Liantou. Financing; On February 14 this year, according to informed sources in the industry, it was assumed that the technology completed the B+ round of financing, and the investor has not disclosed it yet.

According to Chen Kuan, the CEO of Think Technology, this round of financing will be fully invested in the research and development of AI medical imaging products, accelerating the application of other AI products out of the lungs, and the coverage of strong domestic and foreign products.